Pre-existing cross-reactive immune responses to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) proteins in infection-naive subjects have been described by …

This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …

Abstract Purpose of Review In this review, we examine the intersection of the HIV and
COVID-19 epidemics with focus on COVID-19-related health outcomes and risk factors for …

Objectives Available data show that COVID-19 vaccines may be less effective in people
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …

Abstract Purpose of Review HIV/AIDS and COVID-19 have been the major pandemics
overwhelming our times. Given the enduring immune disfunction featuring people living with …

Background People with human immunodeficiency virus (HIV) on antiretroviral therapy
(ART) with good CD4 T-cell counts make effective immune responses following vaccination …

Background: The immunogenicity and safety of COVID-19 vaccines among people living
with human immunodeficiency virus (PLWH) are unclear. We aimed to evaluate the …

We assessed a cohort of people living with human immunodeficiency virus (PLWH)(n= 110)
and HIV negative controls (n= 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all …

Adaptive immune responses play an important role in the clinical course of SARS-CoV-2
infection. While evaluations of the virus-specific defense often focus on the humoral …

Background Longer-term humoral responses to 2-dose coronavirus disease 2019 (COVID-
19) vaccines remain incompletely characterized in people living with human …